Equity In Private Insurance Coverage For Substance Abuse: A Perspective On Parity

Yale University in New Haven, Connecticut, USA.
Health Affairs (Impact Factor: 4.97). 11/2007; 26(6):w706-16. DOI: 10.1377/hlthaff.26.6.w706
Source: PubMed


Congress is considering enactment of comprehensive parity legislation. The intent of parity is to equalize private coverage of behavioral and general medical care, thereby improving efficiency and fairness in insurance markets. One issue is whether to extend parity to substance abuse (SA) benefits. In the past, inclusion of substance abuse has been a hurdle to passage of parity. We examine the politics of SA parity, compare coverage trends for substance abuse and mental health, and assess the rationale for equalizing benefits. We conclude that the justification for SA parity is as compelling as it is for mental health parity.

Download full-text


Available from: Jody Sindelar, Jan 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Data from a nationally representative sample of private health plans reveal that special lifetime limits on behavioral health care are rare (used by 16% of products). However, most plans have special annual limits on behavioral health utilization; for example, 90% limit outpatient mental health and 93% limit outpatient substance abuse treatment. As a result, enrollees in the average plan face substantial out-of-pocket costs for long-lasting treatment: a median of $2,710 for 50 mental health visits, or $2,400 for 50 substance abuse visits. Plans' access to new managed care tools has not led them to stop using benefit limits for cost containment purposes.
    Administration and Policy in Mental Health and Mental Health Services Research 12/2008; 36(1):15-23. DOI:10.1007/s10488-008-0196-5 · 3.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study investigated the association between substance use parity laws and the detection/treatment of co-occurring psychiatric and substance use disorders among adolescents seeking treatment within a mental health setting. Data were drawn from the Substance Abuse and Mental Health Services Administration 1997 Client/Patient Sample Survey (CPSS). The CPSS is a nationally representative survey of mental health service use obtained from standardized chart reviews. While 5.8% of the sample received a substance use diagnosis, only 32% of those youth received substance treatment. Youth receiving services in a state with a substance parity law were more likely to receive a substance use diagnosis and substance treatment compared with youth residing in a state without a substance parity law. Findings suggest that while substance parity laws may influence the detection and treatment of substance use disorders, overall, youth with a dual diagnosis remain underserved.
    Journal of Dual Diagnosis 01/2009; 5(1-1):2-13. DOI:10.1080/15504260802628544 · 0.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The coming decades will see exciting breakthroughs in the treatment of SUDs, such as further elucidation of the genetic mechanisms of addiction. Yet if the past is any guide to the future, each new discovery will bring with it new challenges to the core ethical obligations of honoring informed consent, protecting confidentiality, and respecting justice, while also protecting the public from harm and ensuring the good of the individual patient. For the emerging scientific shift to a biobehavioral model of addiction to transform cultural attitudes and enhance treatment and research will require the scientifically rigorous and ethically sound agency of ethicists and addiction professionals to influence public policy. The growing body of neurobiologic evidence that contests traditional assumptions about free will and responsibility will evoke more deliberate and nuanced approaches to informed consent and treatment participation and dispute the forensic orientation in drug policy. If this unprecedented paradigm change can influence health care decision making in a reasoned and balanced fashion, there is real hope that the cultural stigma, which has warranted highly stringent confidentiality protections, and the disenfranchisement underlying health disparities in addiction treatment may move in the direction of compassionate and competent care for all those who suffer from addiction.
    The Psychiatric clinics of North America 07/2009; 32(2):283-97. DOI:10.1016/j.psc.2009.03.002 · 1.87 Impact Factor
Show more